Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss
A: Most insurance plans do not cover compounded medications, but Rock Ridge Pharmacy offers competitive pricing to increase affordability
Interested members complete an intake questionnaire, submit a body photo, verify their identity and connect with a licensed clinician, who determines whether a microdosed GLP-1 prescription is appropriate
The Skinny Shot is an injectable that is used to help people lose weight
3032 These hypothalamic effects are thought to vary among patients treated with GLP-1 receptor agonists
Matsumoto Y, Marusawa H, Kinoshita K, et al